12岁及以上儿科患者体外膜氧合桥接肺移植的结局
该研究基于UNOS数据回顾2005-2016年12-18岁首次肺移植患者,比较ECMO桥接组(16例)与非桥接组(375例)的结局。桥接组30天生存率88%,1年与3年生存率与非桥接组相似,尽管桥接组病情更重、等待时间更短、肺分配评分更高。结论认为ECMO桥接肺移植在该人群是合理策略。
要点
- ECMO桥接组30天生存率88%,1年与3年生存率与非桥接组无显著差异。
- 桥接组等待时间更短、肺分配评分更高、更可能接受成人供肺。
- 桥接组移植后住院时间更长,且是3年死亡的唯一预测因素。
核心结论
- 对于≥12岁儿科患者,ECMO桥接肺移植是合理策略,手术死亡率可接受,1年和3年生存率与非桥接患者相似。
研究设计与样本
- 回顾性队列研究,查询UNOS数据库2005-2016年12-18岁首次肺移植患者,分为ECMO桥接组(16例)和非桥接组(375例)。
主要发现
- 桥接组等待时间更长者死亡率更高,且更可能接受成人供肺。
临床怎么用
- 对于≥12岁病情危重的儿科肺移植候选者,可考虑ECMO桥接以缩短等待时间并增加接受成人供肺的机会。
- 桥接患者移植后住院时间较长,需关注术后管理及长期生存预测因素。
局限性
- 桥接组样本量小(16例),可能影响统计效能。
- 回顾性数据库研究,存在选择偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a reluctance to using extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation in the pediatric population. Pediatric patients between ages 12 and 18 years are eligible for acuity-based lung transplantation using the Lung Allocation Score and may be suitable for adult allografts, increasing the donor pool and thus leading to a successful bridge to lung transplantation. METHODS: The United Network for Organ Sharing dataset was queried for primary lung transplantation in pediatric patients (12-18 years) from 2005 to 2016. Groups were divided into those who were on ECMO (bridged [BG]) and not on ECMO (nonbridged [NBG]) at the time of listing for lung transplant. RESULTS: The groups comprised 16 BG and 375 NBG patients. Fourteen BG patients (88%) survived the first 30 days. One-year (83.3% vs 86.2%, P = .78) and 3-year (66.7% vs 55.1%, P = .57) survivals were similar in the BG and NBG groups, respectively. Donors in the BG group were more likely to be adults. The median wait-list times were shorter (10.5 [interquartile range {IQR}, 11] vs 93 [IQR, 221] days, P < .001), with a higher Lung Allocation Score (89.8 vs 36.6, P < .001) and similar median ischemic times (5.19 [IQR, 2.32] vs 5.34 [IQR, 1.92] hours, P = .85) in the BG group compared with the NBG group. The median post-transplant length of stay was longer in the BG group (33 [IQR, 31] vs 17 [IQR, 12] days, P = .007) and was the only factor predictive of 3-year mortality. Longer wait-list time had a higher mortality in the BG group. CONCLUSIONS: ECMO as a bridge to lung transplantation is a reasonable strategy in pediatric patients aged ≥ 12 years with acceptable operative mortality and similar 1- and 3-year survival compared with nonbridged patients despite higher acuity. Bridged patients were more likely to receive adult donor lungs.
引用
- Sainathan S, Ryan J, Sharma M, et al. Outcome of Bridge to Lung Transplantation With Extracorporeal Membrane Oxygenation in Pediatric Patients 12 Years and Older. Ann Thorac Surg. 2020. PMID: 33217402. doi:10.1016/j.athoracsur.2020.08.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。